Guglielmo Vetere, Ryan Sun, Van K. Morris, Arvind Dasari, Bryan K. Kee, John Paul Y.C. Shen, Jason Willis, Maria Pia Morelli, Alexey Sorokin, Preeti Kanikarla Marie, Robert A. Wolff, Michael J. Overman, Kanwal Pratap Singh Raghav, Eduardo Vilar Sanchez, Ryan W Huey, Victoria Higbie, Phat Le, Yunyu Baig, Scott Kopetz, Christine Parseghian. "Open-label phase Ib/II study of cetuximab (CET) plus LY3214996 with or without abemaciclib in patients (pts) with anti-EGFR-refractory metastatic colorectal cancer (mCRC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3534